Article Details
Retrieved on: 2021-05-11 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NEW YORK – Day One Biopharmaceuticals said on Tuesday said that it has dosed the first pediatric, low-grade glioma patient in its ...
Article found on: www.precisiononcologynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here